Molecular mechanisms in rare proteasomopathies
Sophie Wolfgramm1, Flavia Llorente Alvarez1, Franziska G Thiel1
1Institute of Medical Biochemistry and Molecular Biology, University Medicine Greifswald, Greifswald, Germany.
EULAR Rheumatology Open
|June 29, 2026
Summary
Proteasomopathies are rare genetic disorders affecting proteasome function, leading to protein imbalance. Structural modeling innovations can accelerate the diagnosis of these complex interferonopathy-related syndromes.
Area of Science:
- Molecular Biology
- Genetics
- Immunology
Background:
- Proteasomopathies are rare interferonopathy-related syndromes stemming from genetic defects in proteasome assembly or function.
- These defects disrupt ubiquitin-mediated protein degradation, causing protein homeostasis imbalance.
- Known phenotypes include autoinflammatory and neurodevelopmental disorders, sharing molecular hallmarks like protein aggregation and altered interferon signaling.
Purpose of the Study:
- To integrate current knowledge of mammalian proteasome biogenesis.
- To analyze known proteasomopathy-causing variants using structural modeling.
- To discuss how structural modeling can improve diagnostic timelines.
Main Methods:
- Review of mammalian proteasome biogenesis literature.
- Structural modeling of proteasome variants.
- Integration of genetic and structural data.
Main Results:
- Characterization of two distinct proteasomopathy phenotypes (autoinflammatory, neurodevelopmental).
- Identification of shared molecular features across phenotypes (protein aggregation, stress responses, interferon dysregulation).
- Demonstration of structural modeling's potential in understanding disease mechanisms.
Conclusions:
- Proteasome dysfunction underlies diverse clinical syndromes with shared molecular pathology.
- Structural modeling offers a promising avenue for accelerating the diagnosis of proteasomopathies.
- Further research integrating structural and genetic data is crucial for clinical management.
Related Concept Videos
The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome Structure
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
Regulated Protein Degradation
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...


